Ropes & Gray represented Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) in its $200 million secondary offering. The transaction closed on Nov. 18.
Zai Lab is a commercial-stage biopharmaceutical company based in China and the United States. The company is focused on discovering, developing, and commercializing innovative products in the areas of oncology, immunology, neuroscience and infectious diseases.
The deal team included capital markets partner Tom Danielski, M&A partner Arthur Mok, litigation & enforcement partner Geoff Atkins, IP transactions partner Melissa Rones, and life sciences partner Katherine Wang.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
